Amyris, Inc. (AMRS) Stock Formed Double Top Chart Pattern. What To Expect?

May 17, 2018 - By Robert Crowder

Amyris, Inc. (NASDAQ:AMRS) Logo

The chart of Amyris, Inc. (AMRS) shows a double top with $5.50 target or 4.00 % above today’s $5.29 share price. The 6 months chart pattern indicates low risk for the $262.89 million company. It was reported on May, 17 by If the $5.50 price target is reached, the company will be worth $10.52M more. Double tops are rare but powerful chart patterns.

The stock decreased 3.99% or $0.22 during the last trading session, reaching $5.29. About 549,677 shares traded. Amyris, Inc. (NASDAQ:AMRS) has declined 7.62% since May 17, 2017 and is downtrending. It has underperformed by 19.17% the S&P500.

Amyris, Inc. (NASDAQ:AMRS) Ratings Coverage

Among 4 analysts covering Amyris (NASDAQ:AMRS), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Amyris had 5 analyst reports since November 28, 2017 according to SRatingsIntel. The firm earned “Buy” rating on Monday, April 2 by H.C. Wainwright. The rating was maintained by B. Riley & Co on Tuesday, March 20 with “Buy”. The firm earned “Buy” rating on Wednesday, November 29 by H.C. Wainwright. The stock has “Hold” rating by Cowen & Co on Tuesday, November 28. FBR Capital initiated Amyris, Inc. (NASDAQ:AMRS) on Thursday, January 25 with “Buy” rating.

More notable recent Amyris, Inc. (NASDAQ:AMRS) news were published by: which released: “Amyris, Inc. 2018 Q1 – Results – Earnings Call Slides” on May 15, 2018, also with their article: “Amyris (AMRS) Reports Q1 Loss of $0.52” published on May 14, 2018, published: “Biossance Launches Mobile Interactive Clean Beauty Consumer Experience” on May 17, 2018. More interesting news about Amyris, Inc. (NASDAQ:AMRS) were released by: and their article: “Amyris’ (AMRS) CEO John Melo on Q1 2018 Results – Earnings Call Transcript” published on May 15, 2018 as well as‘s news article titled: “Future Outlook Of The Energy Industry And Amyris Inc (NASDAQ:AMRS)” with publication date: May 08, 2018.

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company has market cap of $262.89 million. The firm uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable ingredients. It currently has negative earnings. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market.

Amyris, Inc. (NASDAQ:AMRS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: